Cyteir Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cyteir Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2022.
  • Cyteir Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.53M, a 68% increase year-over-year.
  • Cyteir Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$33.2M, a 32.3% increase year-over-year.
  • Cyteir Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.1M, a 9.34% decline from 2021.
  • Cyteir Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42.1M, a 102% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$46.1M -$3.94M -9.34% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 -$42.1M -$21.3M -102% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$20.8M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.